China SXT Pharmaceuticals, Inc.
Asset & Liabilities Breakdown
Asset Breakdown FY2026
Total Assets: $34.8M
Liabilities Breakdown FY2026
Total Liabilities: $5.0M
Asset Breakdown
Total Assets: $34.8M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $28.2M | 81.1% |
| Accounts Receivable | $931.6K | 2.7% |
| Inventory | $777.1K | 2.2% |
| Property, Plant & Equipment | $117.1K | 0.3% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $6.3K | 0.0% |
| Other Assets | $4.7M | 13.7% |
Liabilities Breakdown
Total Liabilities: $5.0M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $497.6K | 9.9% |
| Long-Term Debt | $644.4K | 12.8% |
| Other Liabilities | $3.9M | 77.4% |